Overview

Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis

Status:
Completed
Trial end date:
2002-04-01
Target enrollment:
Participant gender:
Summary
This is a randomized placebo controlled clinical trial designed to investigate the effects of micronized fenofibrate on fasting and postprandial lipoproteins, oxidized fatty acids and lipoproteins, inflammatory mediators and thrombotic factors among hypertriglyceridemic individuals with two or more other characteristics of the metabolic syndrome.
Phase:
N/A
Details
Lead Sponsor:
University of Michigan
Collaborator:
Abbott
Treatments:
Fenofibrate